Literature DB >> 17484295

Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: should it be applied to a recurrent events outcome?

Chris Metcalfe1, Simon G Thompson.   

Abstract

Wei, Lin and Weissfeld (WLW) have applied an elaboration of Cox's proportional hazards regression to the analysis of recurrent events data. This application is controversial and has attracted criticism in a piecemeal fashion over 15 years. A frequently raised concern is the method's 'risk set': each individual is considered to be at risk of all recurrent events from the start of the observation period. The WLW method often gives estimates that exceed those provided by alternative approaches. This paper investigates whether the estimates are a consequence of biased estimation, or reflect a particular aspect of the treatment effect. Simulation studies show that the WLW method infringes the proportional hazards assumption when applied to recurrent events data, but that the bias this may cause is not behind the distinctive effect estimates. Instead, the method's risk set is demonstrated to be responsible, leading to discussion of the interpretation of the treatment effect being estimated. Analyses of medical data indicate that the infringement of the proportional hazards assumption is not necessarily greater than that experienced with other applications of proportional hazards regression and need not prohibit the application of WLW's method to recurrent events data.

Entities:  

Mesh:

Year:  2007        PMID: 17484295     DOI: 10.1177/0962280206071926

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  9 in total

1.  Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults.

Authors:  Marianna K Baum; Shenghan Lai; Sabrina Sales; J Bryan Page; Adriana Campa
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

2.  Estimating the burden of recurrent events in the presence of competing risks: the method of mean cumulative count.

Authors:  Huiru Dong; Leslie L Robison; Wendy M Leisenring; Leah J Martin; Gregory T Armstrong; Yutaka Yasui
Journal:  Am J Epidemiol       Date:  2015-02-17       Impact factor: 4.897

3.  Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients.

Authors:  Ingar Holme; Bengt C Fellström; Alan G Jardine; Anders Hartmann; Hallvard Holdaas
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-15       Impact factor: 8.237

4.  Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study.

Authors:  Jisheng Cui; Andrew Forbes; Adrienne Kirby; Ian Marschner; John Simes; David Hunt; Malcolm West; Andrew Tonkin
Journal:  BMC Med Res Methodol       Date:  2010-04-01       Impact factor: 4.615

5.  Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial.

Authors:  R K Simmons; S J Sharp; A Sandbæk; K Borch-Johnsen; M J Davies; K Khunti; T Lauritzen; G E H M Rutten; M van den Donk; N J Wareham; S J Griffin
Journal:  Diabet Med       Date:  2012-11       Impact factor: 4.359

6.  Analysis of recurrent events with an associated informative dropout time: Application of the joint frailty model.

Authors:  Jennifer K Rogers; Alex Yaroshinsky; Stuart J Pocock; David Stokar; Janice Pogoda
Journal:  Stat Med       Date:  2016-01-10       Impact factor: 2.373

7.  Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

Authors:  Ulrik M Mogensen; Jianjian Gong; Pardeep S Jhund; Li Shen; Lars Køber; Akshay S Desai; Martin P Lefkowitz; Milton Packer; Jean L Rouleau; Scott D Solomon; Brian L Claggett; Karl Swedberg; Michael R Zile; Guenther Mueller-Velten; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2018-02-12       Impact factor: 15.534

8.  Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study.

Authors:  Sameer Parpia; Lehana Thabane; Jim A Julian; Timothy J Whelan; Mark N Levine
Journal:  BMC Med Res Methodol       Date:  2013-03-21       Impact factor: 4.615

9.  On reporting results from randomized controlled trials with recurrent events.

Authors:  Lisa Kuramoto; Boris G Sobolev; Meghan G Donaldson
Journal:  BMC Med Res Methodol       Date:  2008-05-30       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.